Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-27 5:40 pm Purchase |
2025-03-25 | 13D | Savara Inc. SVRA |
Bain Capital Life Sciences Fund II, L.P. | 17,600,621 9.990% |
3,035,164 (+20.84%) |
Filing History |
| 2025-02-14 2:33 pm Purchase |
2024-12-31 | 13G | Savara Inc. SVRA |
Vestal Point Capital, LP | 10,775,000 6.300% |
10,775,000 (New Position) |
Filing History |
| 2025-02-11 5:14 pm Purchase |
2024-12-31 | 13G | Savara Inc. SVRA |
FARALLON CAPITAL PARTNERS LP | 18,288,986 9.990% |
526,453 (+2.96%) |
Filing History |
| 2025-02-10 10:25 am Sale |
2024-12-31 | 13G | Savara Inc. SVRA |
WELLINGTON MANAGEMENT CO LLP | 5,481,654 3.200% |
-3,142,358 (-36.44%) |
Filing History |
| 2024-11-27 11:01 am Purchase |
2024-11-20 | 13G | Savara Inc. SVRA |
Frazier Life Sciences Public Fund, L.P. | 8,660,379 5.000% |
8,660,379 (New Position) |
Filing History |
| 2024-11-14 5:48 pm Sale |
2024-11-14 | 13G | Savara Inc. SVRA |
PRUDENTIAL FINANCIAL INC PRU |
7,410,251 4.500% |
-2,378,052 (-24.29%) |
Filing History |
| 2024-11-12 10:25 am Sale |
2024-09-30 | 13G | Savara Inc. SVRA |
JENNISON ASSOCIATES LLC | 6,732,776 4.100% |
-2,082,582 (-23.62%) |
Filing History |
| 2024-11-12 09:37 am Purchase |
2024-09-30 | 13G | Savara Inc. SVRA |
Adage Capital Management L.P. | 6,753,701 4.100% |
6,753,701 (New Position) |
Filing History |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | Savara Inc. SVRA |
BLACKROCK INC BLK |
9,399,087 5.700% |
0 (Unchanged) |
Filing History |
| 2024-11-08 10:41 am Purchase |
2024-09-30 | 13G | Savara Inc. SVRA |
WELLINGTON MANAGEMENT CO LLP | 8,624,012 5.240% |
8,624,012 (New Position) |
Filing History |
| 2024-11-06 6:32 pm Purchase |
2024-09-30 | 13G | Savara Inc. SVRA |
FARALLON CAPITAL PARTNERS LP | 17,762,533 9.990% |
3,435,622 (+23.98%) |
Filing History |
| 2024-10-24 2:02 pm Purchase |
2024-09-30 | 13G | Savara Inc. SVRA |
BLACKROCK INC BLK |
9,399,087 5.700% |
1,368,473 (+17.04%) |
Filing History |
| 2024-08-14 8:45 pm Unchanged |
2024-08-12 | 13D | Savara Inc. SVRA |
Growth Equity Opportunities 17 LLC | 24,471,264 14.900% |
0 (Unchanged) |
Filing History |
| 2024-07-08 4:32 pm Purchase |
2024-06-30 | 13G | Savara Inc. SVRA |
BLACKROCK INC BLK |
8,030,614 4.900% |
769,084 (+10.59%) |
Filing History |
| 2024-04-12 5:26 pm Purchase |
2024-04-10 | 13D | Savara Inc. SVRA |
Bain Capital Life Sciences Fund II, L.P. | 14,565,457 13.000% |
332,706 (+2.34%) |
Filing History |
| 2024-02-14 8:35 pm Sale |
2023-12-31 | 13G | Savara Inc. SVRA |
Venrock Healthcare Capital Partners II, L.P. | 3,500,000 2.600% |
-2,851,531 (-44.90%) |
Filing History |
| 2024-02-14 4:15 pm Sale |
2024-01-24 | 13G | Savara Inc. SVRA |
Zambon SpA | 4,680,000 3.460% |
-13,540 (-0.29%) |
Filing History |
| 2024-02-13 9:38 pm Purchase |
2024-02-13 | 13G | Savara Inc. SVRA |
PRUDENTIAL FINANCIAL INC PRU |
9,788,303 7.230% |
9,788,303 (New Position) |
Filing History |
| 2024-02-13 9:00 pm Sale |
2023-12-31 | 13G | Savara Inc. SVRA |
CAXTON CORP | 353,441 0.300% |
-6,543,110 (-94.88%) |
Filing History |
| 2024-02-08 1:31 pm Purchase |
2023-12-31 | 13G | Savara Inc. SVRA |
JENNISON ASSOCIATES LLC | 8,815,358 6.500% |
8,815,358 (New Position) |
Filing History |